San Gabriel, CA, United States of America

Kat T Khin


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kat T Khin: Innovator in Therapeutic Delivery Systems

Introduction

Kat T Khin is a prominent inventor based in San Gabriel, California. She has made significant contributions to the field of therapeutic delivery systems, particularly through her innovative work with cyclodextrin-based polymers. Her research focuses on improving drug stability and solubility while reducing toxicity in small molecule therapeutics.

Latest Patents

Kat T Khin holds a patent for "Cyclodextrin-based polymers for therapeutics delivery." This invention relates to novel compositions of therapeutic cyclodextrin-containing polymeric compounds designed as carriers for small molecule therapeutics. The polymers enhance drug stability and solubility, and they minimize toxicity when used in vivo. By selecting various linker groups and targeting ligands, these polymers offer methods for controlled delivery of therapeutic agents. The invention also encompasses methods for treating subjects with these therapeutic compositions and conducting pharmaceutical business related to the polymeric compounds.

Career Highlights

Kat T Khin is associated with Cerulean Pharma Inc., where she continues to advance her research in therapeutic delivery systems. Her work has garnered attention for its potential to revolutionize how small molecule drugs are delivered and utilized in medical treatments.

Collaborations

Kat has collaborated with notable colleagues, including Jianjun Cheng and Mark E Davis, who have contributed to her research endeavors and the development of her patented technologies.

Conclusion

Kat T Khin is a trailblazer in the field of therapeutic delivery systems, with her innovative cyclodextrin-based polymers paving the way for advancements in drug delivery and treatment methodologies. Her contributions are poised to make a lasting impact on the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…